Maricann Group will begin trading today on the Canadian Securities Exchange under the stock symbol MARI.
Maricann Group (CSE:MARI) will begin trading today on the Canadian Securities Exchange under the stock symbol MARI.
As quoted in the press release:
“We have been building a very strong foundation to all aspects of our business over the last four years,” said Ben Ward, CEO of Maricann. “Now, as a public company, we continue to build on that foundation in capitalizing on growth opportunities across the expanding cannabis industry.”
Maricann’s public listing follows a series of recent transactions and approvals. On April 18, 2017, the shareholders of Maricann Inc. (“Old Maricann”), a private company, approved its previously announced reverse takeover transaction of Danbel Ventures Inc. (“Danbel”), a public company. On April 20, 2017 the reverse takeover of Danbel by the shareholders of Old Maricann was completed and Danbel changed its name to “Maricann Group Inc.” Old Maricann became a wholly owned subsidiary of the Company. On April 21, 2107 Maricann received approval to list its shares for trading on the CSE.
“Countless people worked very hard to get Maricann to this point, with our employees, shareholders, board members, senior executives and a range of suppliers putting their faith in our growth strategy,” said Ben. “We are moving forward on the path to becoming one of the world’s leading vertically integrated cannabis companies.”
Maricann is a vertically integrated low cost greenhouse producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal licence to cultivate cannabis and one of approximately 30 independent licensed producers with a federal licence to process and distribute cannabis, Maricann services a patient base with more than 8,000 registered patients. Maricann is currently undertaking an expansion of the cultivation and support facilities to support existing and future patient growth.